Clinical trial
New York Blood Center National Cord Blood Program
NCT00212407 · New York Blood Center, Other · Terminated
Key facts
| NCT number | NCT00212407 |
|---|---|
| Title | New York Blood Center National Cord Blood Program |
| Official title | New York Blood Center National Cord Blood Program |
| Lead sponsor | New York Blood Center, Other |
| Status | Terminated |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Genetic Disease, Severe Aplastic Anemia, Myelodysplasia |
| Intervention type | Biological |
| Interventions | Umbilical Cord Blood Transplantation |
| Enrollment | 4,476 |
| Start date | Feb 1, 1993 |
| Primary completion | Nov 10, 2011 |
| Completion | Nov 10, 2011 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: